Swiss pharma group Roche reported an increase in their global sales in the first half of the year by 5 percent, at a constant exchange rate, reaching CHF 22.9 billion due to the increased demand for cancer and autoimmune drugs, reports a press relese. According to Severin Schwan, Roche CEO, the good results are due to the performance of the cancer drugs, especially those against breast cancer, and the diagnostic division. The R&D division reported major progress as well both in Pharma and Diagnostic areas. )…) Considering the performance of Roche Group over the first six months, I am sure we will meet our targets for 2014,” stressed Schwan. For the current year, Roche forecasts an increase in sales of about 5 percent, for a constant exchange rate and higher dividends.
Liberal Cristian Adomnitei, investigated for favouring an offender, will not run for local elections
Plumb, Oprea assure there are no problems inside the coalition: “We are waiting for PM Ponta to return to the country recovered and yearning to work”
European stock markets little affected by Greek situation •Eurogroup leaders to meet Greek government representatives on Tuesday
Head of the Muslim community in Romania requests former President Basescu not to involve Muslims in political conflict
In Brussels “he who distributes the spoils gets the lion’s share”: Romania benefits from just EUR 860 M from CEF-T
The Nine O’Clock Supplement
Nine O’Clock Announcements
5, Intrarea Armasului, District 1, Bucharest, Telephone: 317.71.36 / 317.71.35, Fax: 317.71.33 / 317.71.39
Nine O`clock Ads
Subscribe to RSS
Subscribe to RSS or enter you email to receive newsletter for news, articles, and updates about what's new.